Tiantom J.

Tiantom (Dom) J. currently serves as Chief Medical Officer and Vice President of Clinical Development at iOmx Therapeutics AG since January 2024. Previously, Tiantom was Vice President of Translational Medicine at Ridgeline Discovery from August 2020 to December 2023. At MorphoSys, from November 2013 to July 2020, Tiantom led global development teams for proprietary assets and managed clinical development responsibilities. Prior experience includes roles at Roche as a Senior Expert Pathologist and Head of Translational Research Sciences in China, focusing on oncology and developing biomarker strategies. Additionally, Tiantom held leadership positions in pathology and tissue biomarkers at Roche from 2008 to 2012 and served as a Resident Medical Doctor in Pathology at University Hospital Schleswig-Holstein from 2004 to 2008. Tiantom earned a Doctor of Medicine (MD) degree from Universität zu Lübeck.